Startups
GlamorousAI is bringing drugs to every target though its AI-first SaaS platform for drug discovery, RosalindAI. RosalindAI advancing AI to address small, noisy and sparse data challenges with a technology validated experimentally in the lab.
Overview
Location
United Kingdom, England, London
Employees
11-50
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 9, 2022 | X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets | LONDON and HYDERABAD, India, Feb. 9, 2022 /PRNewswire/ -- A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to fi... |
Reviews 0
FAQ about GLAMOROUS.AI
What has the press written about GLAMOROUS.AI?
Parsers VC has collected 2 articles mentioning GLAMOROUS.AI, among them “X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets” (Feb 9, 2022).
Is GLAMOROUS.AI still active?
Yes, GLAMOROUS.AI is active; its latest activity on Parsers VC dates from Jul 24, 2023.